$BDSI Company News Microsoft, Starbucks shares rise

New Post Public Reply Private Reply Replies (0) Message Board

Jun 9, 2014 at 10:26 AM

$BDSI Company News

Microsoft, Starbucks shares rise after earnings reports 7:30 p.m. Jan. 23, 2014 - Wallace Witkowski
Top 10 U.S. cities for growing businesses 8:48 p.m. April 15, 2013 - Russ Britt
What 2012’s winners and losers say about 2013 7:00 a.m. Dec. 14, 2012 - Howard Gold
BioDelivery to get milestone payment; shares leap 12:54 p.m. Feb. 16, 2012 - MarketWatch.com
BioDelivery to get up to $180M in Endo Pharma pact 8:03 a.m. Jan. 6, 2012 - MarketWatch.com
Wednesday's biggest stock gainers and decliners 7:20 p.m. April 25, 2007 - MarketWatch
Updates, advisories and surprises 6:31 p.m. April 25, 2007 - MarketWatch
BioDelivery Sciences up 76% at $8.01 9:59 a.m. April 25, 2007 - Tomi Kilgore
BioDelivery Sciences Phase III trial shows positive results 6:39 a.m. April 25, 2007 - Simon Kennedy
BioDelivery Sciences says positive Phase III Fentanyl trial 6:12 a.m. April 25, 2007 - Steve Goldstein
Highlights of rising and falling U.S. stocks 6:15 p.m. March 2, 2006 - MarketWatch
BioDelivery Sciences off after nausea treatment setback 11:57 a.m. March 2, 2006 - Michael Baron
Highlights of rising and falling U.S. stocks 2:23 p.m. Sept. 30, 2005 - Michael Baron
BioDelivery prices 4.4 million shares at $2 each 8:21 a.m. Sept. 30, 2005 - Thomas Middleton
Biodelivery Sciences prices offer of 4.4M shares at $2 per 8:19 a.m. Sept. 30, 2005 - Michael Baron
BioDelivery prices 4.4M shares at $2 each 8:05 a.m. Sept. 30, 2005 - Thomas Middleton
BioDelivery Sciences:FDA to review nausea treatment app 10:49 a.m. July 20, 2005 - Carla Mozee
BioDelivery Sciences:FDA to review nausea treatment app 10:39 a.m. July 20, 2005 - Carla Mozee
BioDelivery Sciences: FDA accepts Emezine for review 10:38 a.m. July 20, 2005 - Carla Mozee
BioDelivery to get $7M for Phase III cancer-pain study 11:39 a.m. July 18, 2005 - Carla Mozee

BioDelivery Sciences International (BDSI): Heavy Pre-Market Activity 8:41 a.m. Today - TheStreet.com
The IBB Likely To Move Higher Along With These Biotechs With Catalysts Upcoming 8:30 a.m. June 2, 2014 - Seeking Alpha
BioDelivery Sciences International Inc Stock Downgraded (BDSI) 11:11 a.m. May 30, 2014 - TheStreet.com
Orexigen Will Run: Here's Why 3:47 p.m. May 27, 2014 - Seeking Alpha
2nd Half Of 2014 Biotechnology Catalysts: Part 1 9:34 a.m. May 27, 2014 - Seeking Alpha
Pipeline Update from BioDelivery Sciences - Analyst Blog 5:50 p.m. May 14, 2014 - Zacks.com
BioDelivery Sciences International's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript) 6:35 a.m. May 14, 2014 - Seeking Alpha
BioDelivery Sciences International Inc Stock Upgraded (BDSI) 11:11 a.m. May 13, 2014 - TheStreet.com
2014 FDA Drug Approval Calendar 9:22 a.m. May 12, 2014 - TheStreet.com
Oversold Conditions For BioDelivery Sciences International (BDSI) 12:08 p.m. April 14, 2014 - TheStreet.com
BioDelivery Sciences' Clonidine in Phase III Study - Analyst Blog 6:25 p.m. April 4, 2014 - Zacks.com
BioDelivery Sciences: 4 Different Insiders Have Sold Shares This Month 3:45 a.m. March 31, 2014 - Seeking Alpha
BioDelivery Sciences and Quintiles Sign Deal for Bunavail - Analyst Blog 11:30 a.m. March 28, 2014 - Zacks.com
Pipeline Update from BioDelivery Sciences - Analyst Blog 5:00 p.m. March 18, 2014 - Zacks.com
BioDelivery Sciences reviews its business and updates milestones for 2014 9:01 a.m. March 14, 2014 - Seeking Alpha
10-K: BIODELIVERY SCIENCES INTERNATIONAL INC 6:14 a.m. March 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
BioDelivery Sciences International (BDSI) Jumps: Stock Up 8.5% - Tale of the Tape 10:39 a.m. Feb. 11, 2014 - Zacks.com
3 Pharmaceutical Stocks to Buy Now 8:15 a.m. Jan. 31, 2014 - InvestorPlace.com
BioDelivery Sciences International (BDSI) Soars: Stock Up 50.6% - Tale of the Tape 9:51 a.m. Jan. 27, 2014 - Zacks.com
Can The Uptrend Continue for BioDelivery Sciences (BDSI)? - Tale of the Tape 8:01 a.m. Jan. 27, 2014 - Zacks.com

BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence 7:00 a.m. Today - PR Newswire - PRF
BioDelivery Sciences Receives FDA Approval for BUNAVAIL™ (buprenorphine and naloxone) Buccal Film for the Maintenance Treatment of Opioid Dependence 5:19 p.m. June 6, 2014 - PR Newswire - PRF
Technical Coverage on Top Gainers -- Research on Noranda Aluminum Holding, Teekay Tankers, BioDelivery Sciences Intl. and Quality Systems 6:00 a.m. May 27, 2014 - PR Newswire - PRF
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of First Quarter 2014 Financials 6:00 p.m. May 8, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference 7:00 a.m. May 8, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Randomization of Over 50% of Subjects in its Initial Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy 7:00 a.m. May 6, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference 9:40 a.m. April 7, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Enrollment of the First Patient in a Phase 3 Clinical Study of Clonidine Topical Gel for Painful Diabetic Neuropathy 7:00 a.m. April 3, 2014 - PR Newswire - PRF
Foresite Capital Closes $300 Million Fund II to Finance Late-Stage Healthcare Companies 8:03 a.m. April 1, 2014 - BusinessWire - BZX
BioDelivery Sciences Announces Commercialization Agreement with Quintiles to Support the Launch of BUNAVAIL in the U.S. 7:00 a.m. March 27, 2014 - PR Newswire - PRF
BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its 2013 Annual Report 6:30 a.m. March 14, 2014 - PR Newswire - PRF
Equities Hitting New High: Allergan, Aetna, Ecolab, and BioDelivery Sciences Intl. 12:17 p.m. March 12, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the 26th Annual ROTH Conference 8:00 a.m. March 5, 2014 - PR Newswire - PRF
BioDelivery Sciences to Present at the Cowen and Company 34th Annual Health Care Conference 8:00 a.m. Feb. 28, 2014 - PR Newswire - PRF
BioDelivery Sciences Closes $60 Million Registered Direct Offering 8:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
BioDelivery Sciences to Raise $60 Million in Registered Direct Offering From Institutional Investors 8:00 a.m. Feb. 10, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Four BUNAVAIL Abstracts to be Presented at the 2014 American Society of Addiction Medicine Annual Conference 8:00 a.m. Jan. 30, 2014 - PR Newswire - PRF
Endo and BioDelivery Sciences Announce Positive Top-Line Results from the Phase III Clinical Trial of BEMA Buprenorphine in Opioid Naive Patients with Chronic Pain 5:30 p.m. Jan. 23, 2014 - PR Newswire - PRF
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets 9:30 a.m. Dec. 3, 2013 - PR Newswire
Positive FDA Meeting Confirms BDSI Phase 3 Program for Clonidine Topical Gel for Treatment of Painful Diabetic Neuropathy 8:00 a.m. Dec. 2, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BULL Faces Class Action After Regulatory Fines

Webull's Financial Quake Shakes Investors You don't expect to wake up to news of a stock in freefall, but here we are with Webull (NASDAQ:BULL) cratering after some rough compliance problems came to light. On November 5, 2026, Webull's stock tumbled nearly 11% thanks to FINRA slapping them with a $4.2 million fine for failing to keep their anti-money laundering (AML) and...

GTEC Faces Nasdaq Bid Price Compliance Challenge

Greenland Technologies in a Tight Spot Man, stocks can be as unpredictable as a cat on a hot tin roof, and Greenland Technologies Holding Corporation (Nasdaq: GTEC) just got a cold splash of reality from Nasdaq. On November 10, 2026, they were handed a Notification Letter that ain’t exactly a love note. Their shares slipped below the one-buck hurdle, and Nasdaq isn’t...

U-wifi Gains Charlie Vogt: Key Steps in 5G Expansion

Charlie Vogt Joins U-wifi: A Broadband Game Changer? There's a new player in town shaking things up, and he's no rookie. Charlie Vogt, five-time technology CEO and Managing Director at Bowen, is hopping onto U-wifi's board of directors. This isn't just about another corporate announcement; it's like adding a veteran quarterback to your expansion team. Vogt’s pedigree in...

Partner Joins Yardi ICN, Boosting Data Quality for Clients

Strategic Alliances in Real Estate Data When Partner Engineering and Science, Inc. says they're hooking up with the Yardi Independent Consultant Network (ICN), that's not just some boardroom handshake. It's a play that could shake up data services in the real estate game. Look, there's plenty of chatter about digitizing property management, but without killer data, those...

Choosing Screen-Free Outdoor Gifts: besrey's Top Picks

The Art of Choosing Outdoor Gifts for Kids Christmas time, my friends, isn't just about plastic gimmicks and gadgets vying for kids' attention. Nope, it's about making thoughtful decisions that blend discovery, movement, and a little peace of mind for parents. This time around, besrey's got the scoop on screen-free gifts that might just do the trick—helping kids explore...

SAHZU Hospital Earns GHA Distinction for Travel Care

A New Benchmark in International Patient Experience When a hospital sets the standard for treating foreign patients like family, it deserves recognition. That's exactly what's happened at The Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU), which just snagged an impressive accolade from Global Healthcare Accreditation (GHA). For anyone keeping...

Cemig and Huawei's Bold Network Leap: Power Up

By Ryan Hughes Updated Nov 13, 2026 Category News Views 100

Taking the Leap in Brazil's Power Grid In Brazil, energy distribution's a whole different beast, and boy, is it complicated! Cemig found out the hard way that relying on public networks was a risky bet. Consistently bad. With a measly 50% coverage in Brazil's vast lands, you're looking at a communications nightmare, especially in the back of beyond where grid faults could...

Revolutionary Sports Ball Backpack: A Game Changer?

Backpacks Reinvented by a Clever Mom Ever been caught in the whirlwind of juggling kids, sports gear, and school supplies? Well, one stay-at-home mom from Poway, California found herself in just such a predicament. She turned this everyday chaos into a creative solution by designing a unique Sports Ball Backpack. The idea came to her while managing a toddler, a newborn,...

DEEPBLUE's Panelized Systems Target Low-Rise Markets

Changing the Game in Low-Rise Construction Been around the block a few times and seen all sorts of hype in this industry, but what DEEPBLUE SMARTHOUSE is pushing sounds more like evolution than revolution for low-rise builds. They're leaning into this panelized building system like a boxer on the ropes—that's their strategy to keep things steady and predictable. The...

DraftKings Shares Tumble, Investors Grapple with Losses

DraftKings' Bold Moves Hit Investor Pockets Hard It ain't every day you see a company gamble nearly $700 million and come out with egg on its face. Yet, that's what DraftKings (NASDAQ: DKNG) seems to have done, and now it's shareholders who might be left holding the bag. On November 6, 2026, when DraftKings admitted it was doubling down on its Predictions business...